Ucb Keppra 1000mg Tablets Recall: Failed Dissolution Specifications
Ucb recalls Keppra 1000mg tablets with failed dissolution specifications. This may affect medication effectiveness. Return or stop using affected lots.
Lower-risk recall
Failed Dissolution Specifications.
Contact the company
What happened, in plain English
Ucb is recalling Keppra 1000mg tablets that failed dissolution tests. This could mean the medication doesn't work properly, which is serious for people taking it for seizures. Read more at govinfonow.com/recall/38266-ucb-keppra-1000mg-tablets-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/38266-ucb-keppra-1000mg-tablets-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-1838-2019
Cite this page
“Ucb Keppra 1000mg Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38266-ucb-keppra-1000mg-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-1838-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1838-2019%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release the medication properly in the body. This could lead to ineffective seizure control. However, the recall is for specific lots and not all Keppra products.
Who’s affected
People prescribed Keppra 1000mg tablets by a doctor. Those with seizure conditions are most at risk if the medication isn't effective.
How to tell if you have this one
Check for the lot number 908946 and expiration date 02/2022 on the bottle. The product is a 60-tablet bottle with NDC 50474-597-66.
- Brand
Ucb- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 908946 and expiration date 02/2022 on the bottle.
Contact Your Doctor
Talk to your doctor about whether you need a different medication if this batch is ineffective.
Where it went and when
Where it was distributed
Distributed in Tennessee.
FDA distribution: “TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class II
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1838-2019 (July 18, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1838-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.